Eugene Clark Rickard

Title: The Innovations of Eugene Clark Rickard

Introduction

Eugene Clark Rickard is a notable inventor based in Zionsville, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized formulations for complex compounds. His work is characterized by a focus on enhancing the stability and efficacy of pharmaceutical formulations.

Latest Patents

Rickard holds a patent for "Stabilized formulations of 6-hydroxy-3-(-4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof." This invention is directed towards pharmaceutical formulations that incorporate 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene or its salts. The formulations are stabilized against oxidation and other forms of decomposition by the inclusion of stabilizing agents such as methionine, acetylcysteine, cysteine, or their salts. This innovation addresses critical challenges in pharmaceutical stability and efficacy.

Career Highlights

Eugene Clark Rickard is associated with Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to contribute to advancements in drug formulation and stability, which are essential for the development of effective medications.

Collaborations

Rickard has collaborated with notable colleagues, including Fadia Najjar Bashore and Kerry John Hartauer. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Eugene Clark Rickard's contributions to pharmaceutical formulations exemplify the importance of innovation in the medical field. His patent for stabilized formulations demonstrates a commitment to improving drug stability and efficacy, which ultimately benefits patient care.